Tirzepatide

A high-purity dual GLP-1/GIP receptor agonist studied for weight and metabolic outcomes. Third-party tested, 99% purity.

Tirzepatide is a synthetic dual GLP-1/GIP receptor agonist studied for glycaemic control and body-weight research. It acts on two incretin pathways at once, the basis for the strong results seen in the SURPASS and SURMOUNT trial programs. Supplied as a lyophilized powder in a sterile vial. 99% purity. Third-party tested by Janoshik Analytical.